Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience

[1] Brennan DC(2006)Rabbit antithymocyte globulin versus basiliximab in renal transplantation N Engl J Med 355 1967-1977

[2] Daller JA(1996)Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3 J Heart Lung Transpl 15 435-442

[3] Lake KD(2003)Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 657-662

[4] Cibrik D(2003)Differential effects of interleukin-2 blockade on apoptosis in naive and activated human lymphocytes Transplantation 75 1631-1635

[5] Del Castillo D(1995)Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation Transplantation 60 748-756

[6] Bonnefoy-Berard N(1995)Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry Transplantation 59 1194-1200

[7] Revillard JP(2005)Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways Transplantation 79 1507-1515

[8] Michallet MC(2010)Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis Transpl Proc 42 1667-1670

[9] Preville X(2006)Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation Transpl Proc 38 2298-2299

[10] Flacher M(2014)Low-dose rabbit anti-thymoglobin globulin versus basiliximab for induction therapy in kidney transplantation Saudi J Kidney Dis Transpl 25 819-822

[1] Brennan DC(2006)Rabbit antithymocyte globulin versus basiliximab in renal transplantation N Engl J Med 355 1967-1977

[2] Daller JA(1996)Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3 J Heart Lung Transpl 15 435-442

[3] Lake KD(2003)Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins Transplantation 75 657-662

[4] Cibrik D(2003)Differential effects of interleukin-2 blockade on apoptosis in naive and activated human lymphocytes Transplantation 75 1631-1635

[5] Del Castillo D(1995)Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation Transplantation 60 748-756

[6] Bonnefoy-Berard N(1995)Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry Transplantation 59 1194-1200

[7] Revillard JP(2005)Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways Transplantation 79 1507-1515

[8] Michallet MC(2010)Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis Transpl Proc 42 1667-1670

[9] Preville X(2006)Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation Transpl Proc 38 2298-2299

[10] Flacher M(2014)Low-dose rabbit anti-thymoglobin globulin versus basiliximab for induction therapy in kidney transplantation Saudi J Kidney Dis Transpl 25 819-822